Latest Share Chat

REMOVE ADS

hVIVO Share News (HVO)

hVIVO Information

Share Price Information for hVIVO (HVO)

Share Price is delayed by 15 minutes

Get Live Data

8.35 0.05 (0.60%)

Bid:

8.20

Ask:

8.50

Spread: 0.30 (3.659%)

Market Cap: £57.48m

Last checked at -

Intraday hVIVO Share Chart

REMOVE ADS

hVIVO News

IN BRIEF: hVIVO Chair and non-exec director sell 30.0 million shares

hVIVO PLC - London-based contract research organisation testing vaccines for infectious and respiratory diseases - Confirms two shareholders, Chair Ca...

IN BRIEF: hVIVO directors to sell total of 14 million shares

hVIVO PLC - London-based contract research organisation testing vaccines for infectious and respiratory diseases - Announces that certain directors in...

hVIVO shares up after "record year" across all metrics

(Alliance News) - hVIVO PLC on Tuesday set a new revenue target of GBP100 million by 2028, after a "strong financial and operational performance" last...

hVIVO inks GBP6.3 million deal to test common cold treatment

(Alliance News) - hVIVO PLC on Tuesday said it signed a contract worth GBP6.3 million to test a potential treatment for the common cold.

hVIVO secures £6.3m contract with biotech client

(Sharecast News) - Infectious and respiratory disease study group hVIVO has inked a £6.3m contract with an unnamed biotechnology client to test a...

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity...

Sunday share tips: hVivo and On the Beach

(Sharecast News) - Drug-testing specialist hVivo was one of the top tips for 2023 from The Daily Mail's Midas column, but the paper still reckons ther...

hVIVO signs deal to test RSV antiviral drug candidate with study model

(Alliance News) - hVIVO PLC on Wednesday said it signed a deal with an unnamed existing client to test a respiratory syncytial virus antiviral drug ca...